Evidence map›Paper›PMID 23241403›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Emanuela Branchetti, Rachana Sainger, Paolo Poggio, Juan B Grau, Jeffrey Patterson-Fortin, Joseph E Bavaria, Michael Chorny, Eric Lai, Robert C Gorman, Robert J Levy and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Emanuela BranchettiDepartment of Surgery, Division of Cardiovascular Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19036, USA.
Rachana Sainger
Paolo Poggio
Juan B Grau
Jeffrey Patterson-Fortin
Joseph E Bavaria
Michael Chorny
Eric Lai
Robert C Gorman
Robert J Levy
Giovanni Ferrari
Centro Cardiologico Monzino · ITColumbia University · USUniversity of Milan · ITChildren's Hospital of Philadelphia · US

Funding

Echocardiography to Predict Recurrent IMR After Surgical Mitral Valve ReplacementR01HL103723 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GORMAN, ROBERT C, HUNG, JUDY W · 2011 to 2020
$5.3M
Osteopontin: a Novel Biomarker for Calcific Aortic Valve DiseasesRC1HL100035 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FERRARI, GIOVANNI · 2009 to 2010
$999k
NHLBI NIH HHS R01 HL103723NHLBI NIH HHS RC1 HL100035NHLBI NIH HHS RC1HL100035
6 · The paper itself

Abstract

objectiveAccumulation of reactive oxygen species (ROS) and remodeling of the microstructure of the cusp characterize aortic valve sclerosis, the early phase of calcific aortic valve disease. These events are associated with activation of valvular interstitial cells (VICs) toward an osteogenic-like phenotype. Because ROS cause DNA damage and transcriptional activation we investigated the relationship between ROS, DNA damage response, and transdifferentiation of VICs. METHODS AND

resultsHuman aortic valve cusps and patient-matched VICs were collected from 39 patients both with and without calcific aortic valve disease. VICs were exposed to hydrogen peroxide (0.1-1 mmol/L) after cell transduction with extracellular superoxide dismutase/catalase adenoviruses and characterized for DNA-damage response, osteogenic transdifferentiation, and calcification. ROS induce relocalization of phosphorylated γH2AX, MRE11, and XRCC1 proteins with expression of osteogenic signaling molecule RUNX2 via AKT. We report a sustained activation of γH2AX in aortic valve sclerosis-derived VICs suggesting their impaired ability to repair DNA damage. Adenovirus superoxide dismutase/catalase transduction decreases ROS-induced DNA damage and VIC transdifferentiation in aortic valve sclerosis-derived cells. Finally, adenoviral transduction with catalase reverts ROS-mediated calcification and cellular transdifferentiation.

conclusionsWe conclude that the ROS-induced DNA damage response is dysfunctional in early asymptomatic stages of calcific aortic valve disease. We unveiled an association among ROS, DNA-damage response, and cellular transdifferentiation, reversible by antioxidant enzymes delivery.

Indexed as

DNA DamageOxidative StressAdenoviridaeAnimalsAortic ValveAsymptomatic DiseasesCalcinosisCatalaseCells, CulturedCell TransdifferentiationCore Binding Factor Alpha 1 SubunitDNA-Binding ProteinsGene Expression Regulation, EnzymologicGenetic VectorsHeart Valve DiseasesHistonesCatalaseCore Binding Factor Alpha 1 SubunitDNA-Binding ProteinsH2AX protein, humanHistonesHydrogen PeroxideMRE11 Homologue ProteinMRE11 protein, humanOxidantsProto-Oncogene Proteins c-aktReactive Oxygen SpeciesRNA, MessengerRUNX2 protein, humanSOD1 protein, humanSod1 protein, mouseSOD3 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2X-ray Repair Cross Complementing Protein 1XRCC1 protein, humanXrcc1 protein, mouse

Identifiers

PMID23241403
PMCPMC4080420
OpenAlexW2149906460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.